10x Genomics Appoints Ansuman Satpathy, Joseph Gilliam to Board
Bitget2026/11/02 21:15- 10x Genomics appointed Ansuman Satpathy and Joseph Gilliam as Class III directors on October 28, 2026, effective immediately.
- Their terms run through the 2028 annual shareholder meeting.
- Gilliam was named chair of the board’s Audit Committee on October 30, 2026.
- Satpathy is a Stanford pathology and immunology associate professor, life sciences entrepreneur and former scientific adviser to the company.
- Gilliam is Glaukos’ president and chief operating officer, previously serving as its chief financial officer and a JPMorgan healthcare investment banking managing director.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Barclays significantly increased holdings in Tesla (TSLA.US) and Intel (INTC.US) in Q3, and bought Nasdaq ETF options for hedging
According to disclosures by the U.S. Securities and Exchange Commission (SEC), Barclays has submitted its third-quarter holdings report (13F) as of September 30, 2026.
SNT Holdings, Related Party Raise Combined Stake in SNTEnergy to 55.75% From 52.75%
Cold wave and rising fuel costs drive electricity prices in northeastern Japan and Tokyo to a four-year high
Japan's spot electricity prices surged to multi-year highs over the weekend.
Google (GOOGL.US) warns that new Australian cybersecurity regulations may cut off minors' access to Gmail
Google stated that a new cybersecurity bill in Australia could prevent minors from using Gmail.
Crypto prices
More
